Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 08, 2018 11:53 ET | Source: Cannabis Science, Inc.

Cannabis Science’s University Scholarship Expo Begins This Weekend; Register Now at the Company’s Flagship Location: CBIS Cali Rx, 14006 Ventura Boulevard, Sherman Oaks, CA

IRVINE, CA, June 08, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the...
June 05, 2018 08:16 ET | Source: Cannabis Science, Inc.

Phase I Underway, Cannabis Science 1,000–Acre Elpasso Farms Economic Development Plan in South Africa; Agriculture, Food Security, Phytomedicines, with an Emphasis on Micro-Nutrients, and Education

Pan African Ambassador for Food Security, Dr. Brylyne Chitsunge, Owner of Elpasso Farms Joins Cannabis Science Scientific Advisory Board IRVINE, CA, June 05, 2018 (GLOBE NEWSWIRE) -- Cannabis...
May 29, 2018 07:48 ET | Source: Cannabis Science, Inc.

Cannabis Science CEO Receives Prestigious Industry Leader Award at 2018 Global Health Catalyst Summit at Harvard Medical School and Announces Major Collaboration With Elpasso Farms in South Africa

BOSTON, MA, May 29, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that the Company has...
May 25, 2018 14:09 ET | Source: Cannabis Science, Inc.

2018 Global Health Catalyst Summit at Harvard Medical School is Streaming Live Now; Watch CBIS Executives Present Live

IRVINE, CA, May 25, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the Company’s participation...
May 14, 2018 07:41 ET | Source: Cannabis Science, Inc.

Cannabis Science President & CEO Mr. Raymond C. Dabney Awarded The 2018 Harvard Global Health Catalyst Industry Leader Award May 25-27th at Harvard Medical School, Boston, MA

IRVINE, CA, May 14, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that Mr. Raymond C. Dabney,...
May 01, 2018 07:44 ET | Source: Cannabis Science, Inc.

Cannabis Science Announces the Second Frontiers Peer-Reviewed Publication of its Research Results on the Use of Cannabinoids in the Treatment of Cancers

IRVINE, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the second publication...
April 27, 2018 10:49 ET | Source: Cannabis Science, Inc.

Inspired by the Upcoming CNN Special Report, Weed: Pot Vs. Pills, by Dr. Sanjay Gupta, Cannabis Science Announces its ‘Cannabis Science to End Opioid Deaths Campaign’

IRVINE, CA, April 27, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and its partner, Cali RX, are...
April 23, 2018 07:55 ET | Source: Cannabis Science, Inc.

Cannabis Science is Proud to Announce 4/20 Success! Opening of the First CBIS Cali Rx Location on Ventura Blvd, in Sherman Oaks, California

IRVINE, CA, April 23, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and its partner, Cali RX, are...
April 10, 2018 07:51 ET | Source: Cannabis Science, Inc.

Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County; Revenue Growth Through Acquisitions, Wholesale, and Retail Sales Channels All Multiply

IRVINE, CA, April 10, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to issue a 2018 First...
March 27, 2018 13:56 ET | Source: Cannabis Science, Inc.

Cannabis Science, Inc. Announces Support for the Global Hemp Group and Senator Mitch Mcconnell's Hemp Legislation; CBIS Ceo Eyes 4/20 for a CBIS Pharmacy Grand Opening Party

IRVINE, CA , March 27, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right